• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估重症 COVID-19 感染患者的器官功能。

Evaluation of organ function in patients with severe COVID-19 infections.

机构信息

Department of Emergency, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing 210008, PR China.

Department of Critical Care Medicine, Huangshi Hospital of TCM(Infectious Disease Hospital), 12 Guangchang Road, Huangshi 435000, PR China, 12 Guangchang Road, Huangshi 435000, PR China.

出版信息

Med Clin (Barc). 2020 Sep 11;155(5):191-196. doi: 10.1016/j.medcli.2020.05.012. Epub 2020 Jun 4.

DOI:10.1016/j.medcli.2020.05.012
PMID:32586669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269959/
Abstract

OBJECTIVE

The purpose of our study was to assess organ function in 102 patients with severe COVID-19 infections, using retrospective clinical analysis.

MATERIAL AND METHODS

A retrospective analysis was conducted on 102 patients with severe COVID-19 infections. The patients were divided into a survival group (n=73) and a non-survival group (n=29) according to their prognosis. The age, sex, underlying diseases, clinical laboratory data within 48h (routine blood tests, ALT, AST, TBIL, ALB, BUN, CR, D-Dimer, PT, APTT, FIB, F VIII:C, CK-MB, CK, and LDH), and ventilation status were collected. The organ functions of these severe COVID-19 patients were assessed by comparing the differences between the two groups.

RESULTS

AST, BUN, CR, CK-MB, LDH, and CK in the non-survival group were higher than those in the survival group, and the differences were statistically significant (P<0.05). D-Dimer, PT, FIB, and F VIII:C in the non-survival group were higher than the values observed in the survival group, and the differences were statistically significant (P<0.05). PLT, AST, BUN, CR, D-Dimer, PT, FIB, F VIII:C, CK-MB, CK, and LDH predicted the area under the ROC curve (AUC) of the COVID19 endpoint events and were 0.721, 0.854, 0.867, 0.757, 0.699, 0.679, 0.715, 0.811, 0.935, and 0.802, respectively.

CONCLUSION

The results showed that there were different degrees of damage to the liver, kidneys, blood coagulation, and heart function in the non-survival group. In addition, PLT, AST, BUN, CR, D-Dimer, PT, FIB, F VIII:C, CK-MB, CK, and LDH had value in evaluating disease prognosis.

摘要

目的

本研究通过回顾性临床分析,评估 102 例重症 COVID-19 感染患者的器官功能。

材料与方法

回顾性分析 102 例重症 COVID-19 感染患者,根据预后分为存活组(n=73)和死亡组(n=29)。收集两组患者年龄、性别、基础疾病、48h 内临床实验室资料(血常规、ALT、AST、TBIL、ALB、BUN、CR、D-Dimer、PT、APTT、FIB、F VIII:C、CK-MB、CK、LDH)及通气情况。比较两组间差异,评估重症 COVID-19 患者的器官功能。

结果

死亡组患者 AST、BUN、CR、CK-MB、LDH、CK 高于存活组,差异有统计学意义(P<0.05);死亡组患者 D-Dimer、PT、FIB、F VIII:C 高于存活组,差异有统计学意义(P<0.05)。PLT、AST、BUN、CR、D-Dimer、PT、FIB、F VIII:C、CK-MB、CK、LDH 对 COVID19 终点事件的预测曲线下面积(AUC)分别为 0.721、0.854、0.867、0.757、0.699、0.679、0.715、0.811、0.935、0.802。

结论

结果显示死亡组患者的肝、肾、凝血及心功能均有不同程度的损伤,且 PLT、AST、BUN、CR、D-Dimer、PT、FIB、F VIII:C、CK-MB、CK、LDH 对评估疾病预后有一定价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c3/7269959/1725980c6da4/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c3/7269959/7dc8ad6a4be6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c3/7269959/1725980c6da4/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c3/7269959/7dc8ad6a4be6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c3/7269959/1725980c6da4/gr2_lrg.jpg

相似文献

1
Evaluation of organ function in patients with severe COVID-19 infections.评估重症 COVID-19 感染患者的器官功能。
Med Clin (Barc). 2020 Sep 11;155(5):191-196. doi: 10.1016/j.medcli.2020.05.012. Epub 2020 Jun 4.
2
Evaluation of organ function in patients with severe COVID-19 infections.重症新型冠状病毒肺炎感染患者的器官功能评估。
Med Clin (Engl Ed). 2020 Sep 11;155(5):191-196. doi: 10.1016/j.medcle.2020.05.015. Epub 2020 Sep 19.
3
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
4
Expressions of SAA, CRP, and FERR in different severities of COVID-19.SAA、CRP 和 FERR 在不同 COVID-19 严重程度下的表达。
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11386-11394. doi: 10.26355/eurrev_202011_23631.
5
[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].2019冠状病毒病患者D-二聚体浓度与炎症因子或器官功能的关系
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):559-563. doi: 10.3760/cma.j.cn121430-20200414-00518.
6
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义:中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
7
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.意大利瓦尔卡莫尼卡地区预测 2019 年冠状病毒病(COVID-19)死亡的实验室指标。
Clin Chem Lab Med. 2020 Jun 25;58(7):1100-1105. doi: 10.1515/cclm-2020-0459.
8
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.基于初始纤维蛋白原与白蛋白比值和血小板计数分析预测 COVID-19 重症。
Platelets. 2020 Jul 3;31(5):674-679. doi: 10.1080/09537104.2020.1760230. Epub 2020 May 5.
9
Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.2019 年新型冠状病毒肺炎确诊和临床诊断患者的临床特征:一项单中心、回顾性、病例对照研究。
Med Clin (Barc). 2020 Oct 23;155(8):327-334. doi: 10.1016/j.medcli.2020.06.055. Epub 2020 Jul 28.
10
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.中国湖南两中心回顾性队列研究 213 例病例:武汉以外地区 COVID-19 严重程度的临床特征和危险因素。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963035. doi: 10.1177/1753466620963035.

引用本文的文献

1
NK Cell Mitochondrial Membrane Potential-Associated Model Predicts Outcomes in Critically Ill Patients with COVID-19.自然杀伤细胞线粒体膜电位相关模型可预测COVID-19危重症患者的预后。
J Inflamm Res. 2024 Jul 5;17:4361-4372. doi: 10.2147/JIR.S458749. eCollection 2024.
2
Lactate dehydrogenase and aspartate aminotransferase levels associated with the severity of COVID‑19: A systematic review and meta‑analysis.乳酸脱氢酶和天冬氨酸转氨酶水平与新型冠状病毒肺炎严重程度的相关性:一项系统评价和荟萃分析。
Exp Ther Med. 2023 Mar 29;25(5):221. doi: 10.3892/etm.2023.11920. eCollection 2023 May.
3
Clinical course of patients with severe SARS-CoV-2 infection co-treatment with Jin Si Herbal Tea in Eastern Taiwan: A retrospective cohort study.

本文引用的文献

1
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.关于 SARS-CoV-2 感染潜在发病机制的假说——病毒性肺炎患者免疫变化的综述。
Emerg Microbes Infect. 2020 Dec;9(1):727-732. doi: 10.1080/22221751.2020.1746199.
2
Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress.打破炎症、氧化应激和凝血之间的恶性循环,纳豆激酶通过抑制 LPS 诱导的炎症和氧化应激提供抗血栓的新见解。
Redox Biol. 2020 May;32:101500. doi: 10.1016/j.redox.2020.101500. Epub 2020 Mar 11.
3
台湾东部严重新型冠状病毒肺炎感染患者联合饮用金丝凉茶的临床病程:一项回顾性队列研究
J Herb Med. 2022 Dec;36:100610. doi: 10.1016/j.hermed.2022.100610. Epub 2022 Oct 28.
4
Development of a Mortality Prediction Model in Hospitalised SARS-CoV-2 Positive Patients Based on Routine Kidney Biomarkers.基于常规肾脏生物标志物的住院 SARS-CoV-2 阳性患者死亡率预测模型的建立。
Int J Mol Sci. 2022 Jun 30;23(13):7260. doi: 10.3390/ijms23137260.
5
Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.锂治疗阿尔茨海默病和 COVID-19 的潜在机制。
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369.
6
A look back at the first wave of COVID-19 in China: A systematic review and meta-analysis of mortality and health care resource use among severe or critical patients.回顾中国的 COVID-19 第一波疫情:严重或危重症患者的死亡率和医疗资源利用的系统评价和荟萃分析。
PLoS One. 2022 Mar 11;17(3):e0265117. doi: 10.1371/journal.pone.0265117. eCollection 2022.
7
Alterations in immune-inflammatory indices and hematological parameters in COVID-19 patients: with positive RT-PCR.新型冠状病毒肺炎(COVID-19)患者免疫炎症指标和血液学参数的变化:逆转录聚合酶链反应(RT-PCR)呈阳性者
New Microbes New Infect. 2022 Jan;45:100963. doi: 10.1016/j.nmni.2022.100963. Epub 2022 Feb 4.
8
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.新型冠状病毒肺炎患者的肝脏生化检查异常与急性肝损伤:当前证据及潜在发病机制
Diseases. 2021 Jul 1;9(3):50. doi: 10.3390/diseases9030050.
9
Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression.血清肌酸激酶同工酶(CK-MB)、COVID-19 严重程度和死亡率:一项更新的系统评价和荟萃分析及荟萃回归分析。
Adv Med Sci. 2021 Sep;66(2):304-314. doi: 10.1016/j.advms.2021.07.001. Epub 2021 Jul 7.
10
A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19.一项关于中等程度 COVID-19 患者临床病程的回顾性队列研究。
Front Public Health. 2021 Apr 26;9:593109. doi: 10.3389/fpubh.2021.593109. eCollection 2021.
COVID-19: consider cytokine storm syndromes and immunosuppression.
2019冠状病毒病:考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
4
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.血小板与淋巴细胞比值与新型冠状病毒肺炎患者预后相关。
J Med Virol. 2020 Sep;92(9):1533-1541. doi: 10.1002/jmv.25767. Epub 2020 Mar 26.
5
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Comorbidities and multi-organ injuries in the treatment of COVID-19.新型冠状病毒肺炎治疗中的合并症与多器官损伤
Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.
8
A Review of Coronavirus Disease-2019 (COVID-19).新型冠状病毒肺炎(COVID-19)概述。
Indian J Pediatr. 2020 Apr;87(4):281-286. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.